Galapagos NV (Galapagos)

Oncology Corporate Profile

HQ Location

Industriepark Mechelen Noord, Generaal De Wittelaan L11 A3
Mechelen, Belgium B-2800

Company Description

Galapagos is a mid-size clinical stage biotechnology company specialized in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The company has small molecule programs in the areas of bone and joint diseases, bone metastasis, cachexia, anti-infectives, and metabolic and inflammatory diseases.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
GLPG0492selective androgen modulator (SARM)Cancer cachexiaI
GLPG0187integrin receptor antagonist (IRA)Various cancer typesI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display